- Credit Amounts:
- CME: 1.00
- CNE: 1.00
- Other: 1.00
- CDE: 1.00
- Cost: Free
- Release: Oct 21, 2016
- Expires: Oct 20, 2019
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
KASPER Program Manager
Office of Inspector General
Kentucky Cabinet for Health and Family Services
Needs StatementDrug overdose is a huge problem facing the health care system in Kentucky. Drug overdose deaths are acute poisoning deaths due to prescription or illicit drugs. According to data from the National Center for Health Statistics, Kentucky had the second highest drug overdose death rate in the US in 2013.
The Kentucky Governor, Office of Drug Control Policy, Attorney General and legislators viewed medical community as contributors to the problem and there is a low provider utilization of PDMP (KASPER). Controlled substance prescribers and dispensers in Kentucky may not be fully aware of the most current statutory and regulatory requirements regarding their use of the Kentucky All Schedule Prescription Electronic Reporting (KASPER) system.
This training is an update on provider requirements for use of KASPER and explain the KASPER system enhancements to increase KASPER effectiveness and ease of use.
Target AudienceControlled substance prescribers and dispensers in Kentucky
ObjectivesUpon completion of this educational activity, participants will be able to:
- Describe statutory and regulatory requirements for provide use of KASPER
- Discuss ways to use eKASPER more effectively
- Identify resources available to help providers address doctor shoppers or drug diverters
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, and Kentucky Office of Drug Control Policy. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
This training has been approved by the KBML as meeting the statutory requirements of HB1.
- Patient care
- Medical knowledge
The University of Kentucky, College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
This educational activity is offered for a maximum of 1.00 ANCC contact hour.
The Kentucky Board of Nursing (KBN) approves The University of Kentucky, College of Nursing (UKCON) as a provider as well. ANCC and KBN approval of a continuing nursing education provider does not constitute endorsement of program content nor commercial sponsors. The University of Kentucky does not approve commercial products. This educational activity is offered for a maximum of 1.2 KBN contact hours.
Provider #: 3-0008-01-18- 858. In order to receive credit, participants complete this CNE activity and submit a credit application and evaluation form online. Certificates may be printed once the evaluation is completed.Other
UK Healthcare CECentral certifies this activity for 1.00 hour of participation. CDE
This online course meets regulatory requirements for 1.00 hour credit as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.
Faculty DisclosureMichelle Lofwalll, MD (planner) has relevant financial relationships with commercial interests as follows:
- Braeburn Pharmaceuticals - Consultant and Principal Investigator - Consulting Fees and Research Contract
- PCM Scientific - Speaker - Honoraria
No speaker or other planners have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speaker. In some cases, the presentation might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. The speaker will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.